22157.jpg
Global Infectious Disease Diagnostics Market Report 2022-2032: Shift in Focus from Centralized Laboratories to Decentralized POC Testing Bolsters Growth
29 juin 2023 04h03 HE | Research and Markets
Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Infectious Disease Diagnostics Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering.Growing Prevalence of Infectious...
Global Infection Surveillance Solutions Market
Global Infection Surveillance Solutions Market 2023 - 2030: Increasing Adoption of Inorganic Growth Strategies Fuels the Sector
19 avr. 2023 10h33 HE | Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User (Hospitals, Clinics, Ambulatory Surgical Center,...
Global Market for Infection Surveillance Solutions
Global Infection Surveillance Solutions Markets, 2020-2021 & 2022-2026: Growing Number of HAIs, Continuing Advancements and Innovations and More Expenditure on Healthcare Driving Growth
05 avr. 2022 07h38 HE | Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
U.S. Infection Prevention and Control (IPC) in Outpatient Care Facilities: COVID-19 Pandemic, Healthcare Staff Shortage and Digital Tools Boost IPC Solution Adoption
25 févr. 2022 06h38 HE | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "United States Infection Prevention and Control (IPC) in Outpatient Care Facilities Growth Opportunities" report has been added to...
22157.jpg
Global Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products Market Report to 2026 - Featuring Gilead Sciences, Merck and Novartis Among Others
01 juil. 2021 04h53 HE | Research and Markets
Dublin, July 01, 2021 (GLOBE NEWSWIRE) -- The "Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products: 2021-2026" report has been added to ResearchAndMarkets.com's...
Mark Neaman Photo
EPA Approves New, Broader Pathogen Killing Claims for Applied Silver’s SilvaClean® Commercial Laundry Additive Now Used in Healthcare and Sports Medicine Programs
28 mars 2019 13h19 HE | Applied Silver Inc.
EPA Agrees SilvaClean® Kills MRSA and a Broad Range of Antibiotic-Resistant Pathogens Company Appoints Mark Neaman, former Chairman, President and CEO of NorthShore (IL) University Health Systemto...